all - Opinion Summaries
Page 22 of 88
Showing Result 211 - 220 of 874
| Description | Date | Docket # |
|---|---|---|
Teva Pharmaceuticals USA v. Sandoz Inc.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentThe district court's judgment that various claims of the nine patents-in-suit related to a drug used in treating multiple sclerosis, are infringed,... |
07/26/2013 | 12-1567 |
In re: Bimeda Research & DevelopmentUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentThe decision of the Patent Trial and Appeal Board rejecting certain claims introduced in the context of ex parte reexamination of claimant's patent,... |
07/25/2013 | 12-1420 |
Mylan Inc. v. SmithKline Beecham CorporationUnited States Third Circuit
Contracts, Drugs & Biotech, Injury & Tort LawSummary judgment to defendants in a dispute over competing rights over the rights to sell the pharmaceutical paroxetine in generic form is: 1)... |
07/22/2013 | 12-1539 |
Novozymes A/S v. Dupont Nutrition BiosciencesUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentJudgment for defendants in a patent infringement suit involving competitors in the market for enzyme preparations used in a variety of commercial... |
07/22/2013 | 12-1433 |
E.D. v. Pfizer, Inc.United States Fourth Circuit
Civil Procedure, Drugs & Biotech, Injury & Tort Law, Product LiabilityIn a products liability and negligence suit brought by 19 families against pharmaceutical companies, alleging the antidepressant drug Zoloft caused... |
07/12/2013 | 12-2188 |
Smith & Nephew, Inc. v. ReaUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentA decision of the Board of Patent Appeals and Interferences that certain claims of a patent owned by defendant Synthes, related to a system for using... |
07/09/2013 | 12-1343 |
Watkins v. Vital Pharmaceuticals, Inc.United States Ninth Circuit
Civil Procedure, Class Actions, Consumer Protection Law, Drugs & Biotech, False AdvertisingThe district court's sua sponte order remanding this putative class action to state court is reversed and remanded, where: 1) the court has appellate... |
07/02/2013 | 13-55755 |
Fresenius USA, Inc. v. Baxter International, Inc.United States Federal Circuit
Constitutional Law, Drugs & Biotech, Intellectual Property, PatentThe cancellation of the asserted claims of defendant's '434 patent, which teaches the use of a dialysis machine with an integrated touch screen... |
07/02/2013 | 12-1334 |
Wyeth v. Abbott LaboratoriesUnited States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentSummary judgment for defendant that claims 1 and 2 of plaintiff's '781 patent and claim 1 of plaintiff's '146 patent, which relate to methods for... |
06/26/2013 | 12-1223 |
Mutual Pharmaceutical Co., Inc. v. BartlettUnited States Supreme Court
Administrative Law, Constitutional Law, Drugs & Biotech, Injury & Tort Law, Product LiabilityState-law design-defect claims that turn on the adequacy of a drug's warnings are pre-empted by federal law under PLIVA. Inc. v. Mensing, which held... |
06/24/2013 | 12-142 |
Results 211 to 220 of 874